Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric

Edward O Mason1, Linda B Lamberth, Wendy A Hammerman

  • 1Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, and Infectious Disease Research Laboratory, Texas Children's Hospital, Houston, Texas 77030, USA. emason@bcm.edu

Insights

Vancomycin minimum inhibitory concentrations (MICs) for pediatric Staphylococcus aureus isolates show a slight increase since 2005. Therapeutic decisions require careful consideration of the testing methodology used for MIC determination.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Staphylococcus aureus infections are common in pediatric settings.
  • Vancomycin is a critical antibiotic for treating resistant strains like methicillin-resistant S. aureus (MRSA).
  • Monitoring vancomycin MIC trends is essential for effective treatment strategies.

Purpose of the Study:

  • To investigate the trend of vancomycin minimum inhibitory concentrations (MICs) in pediatric Staphylococcus aureus isolates over a 7-year period.
  • To compare MICs determined by broth microdilution and Etest methods.
  • To assess the impact of infection source and duration of bacteremia on vancomycin MICs.

Main Methods:

  • Analysis of 165 Staphylococcus aureus isolates from pediatric patients over 7 years.
  • Comparison of vancomycin MICs using broth microdilution and Etest.
  • Categorization of isolates by resistance (MRSA/MSSA), acquisition (nosocomial, community-acquired, healthcare-associated), and bacteremia duration.

Main Results:

  • Broth microdilution showed most isolates had MICs < 1.0 µg/ml, while Etest indicated 96% had MICs ≥ 1 µg/ml.
  • Etest detected a significant increase in vancomycin MICs after study year 4 (2004-2005), but broth microdilution did not.
  • No significant difference in MICs was observed based on isolate origin or duration of bacteremia.

Conclusions:

  • Vancomycin MICs in pediatric S. aureus isolates have slightly increased since 2005.
  • Discrepancies between broth microdilution and Etest highlight the importance of methodology in interpreting MIC values.
  • Clinical decisions regarding vancomycin therapy must account for the specific MIC testing method employed.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...